Latest Breaking News On - Curium pharmaceuticals - Page 2 : comparemela.com

Search jobs 25-May-2021 Therapeutic Nuclear Medicines Market – Global Business Dynamics, Industry Opportunities, Risk And Driving Force 2028 | Bayer AG, Novartis AG, GE Healthcare, Curium Pharmaceuticals & so on… According to a new market study by Future Market Insights (FMI), the global therapeutic nuclear medicines market will expand at a healthy rate between 2018 and 2028. The growth of the market is majorly attributed to factors such as the growing acceptance rate of therapeutic nuclear medicines, also known as radiopharmaceuticals, among consumers and medical professionals. These medicines have proven to be largely free of negative side-effects and minimal risk factors. Furthermore, the rising prevalence of prostate cancer is acting as a major growth attribute to the market. As the per statistics of the U.K. cancer research organization, prostate cancer is the most prevalent cancer among men with over 47,151 cases being d

United statesAsia pacificEckert zieglerBayer agProgenics pharmaceuticals incSpectrum pharmaceuticalsCurium pharmaceuticalsDrugs administrationLantheus medical imaging incTherapeutic nuclear medicines marketInternational isotopes incAmerican cancer societyGe healthcareFuture market insightsNuclear medicines marketQueries linked